Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.

Received from

Pending at the end of last month

Received

Resolved*

Total Pending #

Pending complaints >3months

Average Resolution time^ (in days)

Directly from Investors

SEBI (SCORES)

Other Sources (if any)

Grand Total

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.

Month

Carried forward from previous month

Received

Resolved*

Pending#

Jun, 2026

Jul, 2026

Aug, 2026

Grand Total

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Sr. No.

Fin. Year

Carried forward from previous year

Received

Resolved*

Pending#

2022-23

2023-24

2024-25

2025-26

Grand Total

Top Pharma Companies in India by Market Cap

BSE Sensex 74459.53 308.49 (0.42%)

Filter

Top Pharma Companies in India as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

Expand company details	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)	More company information
121	Torrent Pharmaceuticals Ltd.	Q V+ PT	1,76,306 Large Cap	4,635.15 (1.56%)	83.01	9.6	11.80	13.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
122	Wanbury Ltd.	Q V+ PT	664 Small Cap	189.75 (5.10%)	15.44	9.89	10.29	30.27	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
123	Kwality Pharmaceuticals Ltd.	Q V+ PT	3,604 Small Cap	3,473.55 (-5.63%)	44.47	10.11	13.94	34.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
124	Abbott India Ltd.	Q V PT	54,384 Mid Cap	25,593.30 (-1.97%)	33.68	10.51	9.96	17.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
125	Apollo Hospitals Enterprise Ltd.	Q V+ PT	1,20,779 Large Cap	8,400 (2.46%)	76.88	11.71	14.92	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
126	Dr. Lal Pathlabs Ltd.	Q V PT	31,997 Small Cap	1,906.30 (-0.37%)	58.73	12.44	12.18	13.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
127	Neuland Laboratories Ltd.	Q V+ PT	25,276 Small Cap	19,701.10 (2.21%)	50.78	12.51	16.64	37.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
128	Sai Life Sciences Ltd.	Q V+ PT	33,139 Small Cap	1,559.70 (4.33%)	91.61	12.98	23.61	39.96	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
129	Suven Life Sciences Ltd.	Q V+ PT	7,293 Small Cap	258.10 (-2.53%)	N/A	13.1	-12.01	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
130	Thyrocare Technologies Ltd.	Q V PT	7,274 Small Cap	457 (-11.30%)	50.44	13.14	10.88	8.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
131	Aster DM Quality Care Ltd.	Q V+ PT	59,570 Mid Cap	683.40 (0.66%)	186.93	14.08	-11.61	19.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
132	Divis Laboratories Ltd.	Q V+ PT	2,57,903 Large Cap	9,715 (0.62%)	88.17	14.6	8.67	4.44	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
133	Vijaya Diagnostic Centre Ltd.	Q V+ PT	14,906 Small Cap	1,447.25 (-1.19%)	79.51	14.8	16.66	14.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
134	Anthem Biosciences Ltd.	Q V PT	46,685 Mid Cap	828.45 (-0.31%)	81.06	14.92	14.00	16.46	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
135	CORONA Remedies Ltd.	Q V+ PT	13,125 Small Cap	2,146.05 (-3.12%)	63.4	16.3	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
136	Glaxosmithkline Pharmaceuticals Ltd.	Q V PT	42,073 Mid Cap	2,483.55 (-1.28%)	39.39	16.69	5.49	17.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
137	Acutaas Chemicals Ltd.	Q V+ PT	32,770 Small Cap	4,002.65 (0.53%)	74.62	17.64	31.50	70.35	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
138	Rubicon Research Ltd.	Q V+ PT	26,650 Small Cap	1,609.90 (3.16%)	92.47	19.85	41.00	54.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
139	Laurus Labs Ltd.	Q V+ PT	1,29,243 Mid Cap	2,392 (6.55%)	96.46	21.33	7.19	-2.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anuh Pharma	87.09	8.86%
Laurus Labs	2,392	6.55%
SMS Pharmaceuticals	511.75	5.33%
Wanbury	189.75	5.10%
Zydus Lifesciences	1,244	4.89%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
RPG Life Sciences	2,572.40	-14.13%
Thyrocare Tech.	457	-11.30%
Gennex Laboratories	8.02	-10.49%
Ind-Swift Labs.	367.40	-10.14%
Cohance Lifesciences	444.45	-7.67%

News about Top Pharma Companies in India

Oct, 2026

Corona Remedies informs about newspaper publication

Corona Remedies has informed that the Board of Directors, at its meeting held on Friday, October 30, 2026 had considered and approved the Unaudited Financial Results of the Company (Standalone and Consolidated) for the second quarter and half year ended on September 30, 2026. Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, they are enclosed the newspaper advertisement of the Unaudited Financial Results, published today in Financial Express (English and Gujarati). The extract of aforesaid newspaper publication is also being made available on the website of the Company at www.coronaremedies.com

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Wanbury zooms on securing GMP Compliance Certificate for Tanuku Plant from Australia's TGA

The certificate was issued on October 28, 2026 and is valid until December 9, 2028

Oct, 2026

Wanbury secures GMP Compliance Certificate for Tanuku Plant from Australia's TGA

The certificate was issued on October 28, 2026 and is valid until December 9, 2028

Oct, 2026

Laurus Labs hits 52-week high on reporting over two-fold jump in Q2 consolidated net profit

The total consolidated income of the company has increased by 32.07% at Rs 2,219.38 crore for Q2FY27

Oct, 2026

Laurus Labs reports over two-fold jump in Q2 consolidated net profit

The total consolidated income of the company has increased by 32.07% at Rs 2,219.38 crore for Q2FY27

Oct, 2026

Rubicon Research informs about updates

Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Rubicon Research has informed that the United States Food and Drug Administration (US FDA) conducted an unannounced inspection (triggered by a product filing) of the company’s manufacturing facility located at Plot No. K30/4 & 30/5, Additional M.I.D.C., Anand Nagar, Ambernath, Maharashtra, India from Wednesday, 21 October 2026 to Thursday, 29 October 2026. This was a comprehensive GMP inspection in addition to the product application under review. Upon conclusion, a Form 483 containing 3 observations with respect to system improvement and 2 observations with respect to product application under review were issued, all 5 of which are procedural in nature and do not relate to data integrity. The company is confident of working closely with the regulator to successfully conclude the evaluation in a timely manner. All its manufacturing as well as R&D facilities have now been inspected by the US FDA in the recent past and it has enclosed the status of all its operational facilities.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Sanofi Consumer Healthcare India Ltd.	7,911 Crore
2	Evonile Pharma Ltd.	4,182 Crore
3	KMC Speciality Hospitals (India) Ltd.	2,422 Crore
4	Sanofi India Ltd.	7,380 Crore
5	Dr Agarwals Eye Hospital Ltd.	2,552 Crore
6	Gujarat Themis Biosyn Ltd.	4,718 Crore
7	Medico Remedies Ltd.	155 Crore
8	Procter & Gamble Health Ltd.	9,436 Crore
9	Supriya Lifescience Ltd.	6,810 Crore
10	Indraprastha Medical Corporation Ltd.	2,797 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,593	54,384	33.68	10.51	23.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,635	1,76,306	83.01	9.60	33.08	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,308	65,137	36.23	5.94	12.08	27.89
Lupin Ltd. (M)	Somewhat Good	2,009	91,870	16.62	3.86	9.20	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,512	43,891	34.76	9.03	23.33	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,392	1,29,243	147
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	69.37
Gland Pharma Ltd. (M)	Very Good	3,098	51,112	61.94
Aurobindo Pharma Ltd. (M)	Very Good	1,678	96,537	52.18
Ipca Laboratories Ltd. (M)	Very Good	1,928	48,907	49.58
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	91.61	12.98	47.25	23.61
Mankind Pharma Ltd. (M)	Very Good	2,489	1,02,797	45.84	5.85	24.28	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,512	43,891	34.76	9.03	23.33	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,244	1,24,089	27.50	4.60	15.32	13.52
Gland Pharma Ltd. (M)	Very Good	3,098	51,112	45.28	4.81	23.17	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	91.61	12.98	47.25	39.96
Lupin Ltd. (M)	Somewhat Good	2,009	91,870	16.62	3.86	9.20	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,308	65,137	36.23	5.94	12.08	22.19
Abbott India Ltd. (M)	Very Good	25,593	54,384	33.68	10.51	23.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,350	1,12,699	40.25	2.90	18.79	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Corona Remedies informs about newspaper publication

Wanbury zooms on securing GMP Compliance Certificate for Tanuku Plant from Australia's TGA

Wanbury secures GMP Compliance Certificate for Tanuku Plant from Australia's TGA

Laurus Labs hits 52-week high on reporting over two-fold jump in Q2 consolidated net profit

Laurus Labs reports over two-fold jump in Q2 consolidated net profit

Rubicon Research informs about updates

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?